Medicare Part D premiums are projected to increase sharply in 2027, with KFF analysis indicating an average rise of about 50%. News coverage highlights that the average monthly premium for stand-alone Medicare Part D drug plans is expected to go from $34 in 2026 to $51 in 2027.
Several outlets emphasize what beneficiaries may face if they remain in their current plans. Fierce Healthcare and other reports say KFF finds the higher costs could extend beyond premiums to include deductibles and other out-of-pocket expenses. In addition, BioPharma Dive and Healthcare Dive focus on how costs can vary widely across different plans, and urge beneficiaries to shop carefully.
Overall, the sources align on the direction and scale of the premium increases and on KFF’s guidance to review coverage options during Medicare open enrollment, though they differ slightly in which cost components and practical advice they foreground.
